Narayana Hrudayalaya Management

Management criteria checks 2/4

We currently do not have sufficient information about the CEO.

Key information

Emmanuel Rupert

Chief executive officer

₹141.1m

Total compensation

CEO salary percentage	33.4%
CEO tenure	5.3yrs
CEO ownership	n/a
Management average tenure	5.3yrs
Board average tenure	4yrs

Recent management updates

Recent updates

CEO Compensation Analysis

How has Emmanuel Rupert's remuneration changed compared to Narayana Hrudayalaya's earnings?
Date	Total Compensation	Salary	Company Earnings
Dec 31 2023	n/a	n/a	₹8b
Sep 30 2023	n/a	n/a	₹7b
Jun 30 2023	n/a	n/a	₹7b
Mar 31 2023	₹141m	₹47m	₹6b
Dec 31 2022	n/a	n/a	₹5b
Sep 30 2022	n/a	n/a	₹4b
Jun 30 2022	n/a	n/a	₹4b
Mar 31 2022	₹56m	₹33m	₹3b
Dec 31 2021	n/a	n/a	₹3b
Sep 30 2021	n/a	n/a	₹3b
Jun 30 2021	n/a	n/a	₹2b
Mar 31 2021	₹39m	₹28m	-₹143m
Dec 31 2020	n/a	n/a	-₹704m
Sep 30 2020	n/a	n/a	-₹798m
Jun 30 2020	n/a	n/a	-₹310m
Mar 31 2020	₹31m	₹30m	₹1b
Dec 31 2019	n/a	n/a	₹1b
Sep 30 2019	n/a	n/a	₹1b
Jun 30 2019	n/a	n/a	₹936m
Mar 31 2019	₹6m	₹4m	₹592m

Compensation vs Market: Emmanuel's total compensation ($USD1.69M) is above average for companies of similar size in the Indian market ($USD565.89K).

Compensation vs Earnings: Emmanuel's compensation has increased by more than 20% in the past year.

CEO

Emmanuel Rupert (56 yo)

5.3yrs

Tenure

₹141,095,882

Compensation

Dr. Emmanuel Rupert serves as Managing Director and Group Chief Executive Officer of Narayana Hrudayalaya Limited since February 11, 2019 and also serves as its Director since February 03, 2019. Dr. Rupert...

Leadership Team

Name	Position	Tenure	Compensation	Ownership
Devi Shetty	Founder & Executive Chairman	23.8yrs	₹119.31m	16.77% ₹ 43.8b
Emmanuel Rupert	MD, Group CEO & Director	5.3yrs	₹141.10m	no data
Viren Shetty	Executive Vice-Chairman and Senior VP of Strategy & Planning	16.1yrs	₹27.60m	5.03% ₹ 13.2b
Sandhya Jayaraman	Group Chief Financial Officer	2.4yrs	₹25.61m	no data
Seshiah Sridhar	Group Company Secretary	7.2yrs	₹6.62m	no data
R. Venkatesh	Group Chief Operating Officer	1.1yrs	₹5.20m	no data
Nishant Singh	Vice President of Finance	no data	no data	no data
Ashish Bajaj	Chief Marketing Officer	1.8yrs	no data	no data
Sirshendu Mookherjee	Group Head of Human Resources	no data	no data	no data
Srikanth Raman	Group Head of Internal Audit	no data	₹5.97m	no data
K. Kumar	Group Head of Information Technology	7.9yrs	no data	no data
Milind Inamdar	Senior Vice-President of Supply Chain	10.3yrs	no data	no data

5.3yrs

Average Tenure

56yo

Average Age

Experienced Management: 539551's management team is seasoned and experienced (5.3 years average tenure).

Board Members

Name	Position	Tenure	Compensation	Ownership
Devi Shetty	Founder & Executive Chairman	23.8yrs	₹119.31m	16.77% ₹ 43.8b
Emmanuel Rupert	MD, Group CEO & Director	5.3yrs	₹141.10m	no data
Viren Shetty	Executive Vice-Chairman and Senior VP of Strategy & Planning	16.1yrs	₹27.60m	5.03% ₹ 13.2b
Nachiket Mor	Independent Director	1.3yrs	₹100.00k	no data
Kiran Mazumdar-Shaw	Non-Executive Director	16.3yrs	₹2.13m	2.32% ₹ 6.1b
Terri Bresenham	Independent Director	2.8yrs	₹2.42m	no data
Naveen Tewari	Independent Director	1.2yrs	₹50.00k	no data
Shankar Arunachalam	Independent Director	1.3yrs	₹100.00k	no data

4.0yrs

Average Tenure

61yo

Average Age

Experienced Board: 539551's board of directors are considered experienced (4 years average tenure).

Narayana Hrudayalaya Management

Management criteria checks 2/4

Key information

Recent management updates

Narayana Hrudayalaya Limited Announces Board Retirements, Effective August 7, 2023

Narayana Hrudayalaya Limited, Annual General Meeting, Aug 04, 2023

Narayana Hrudayalaya Limited Announces Board Appointments

Insufficient new directors

Narayana Health Announces Appointment of Ashish Bajaj as the Chief Marketing Officer

Insufficient new directors

Recent updates

Price target increased by 8.1% to ₹1,390

Third quarter 2024 earnings: EPS and revenues miss analyst expectations

Narayana Hrudayalaya Limited to Report Q3, 2024 Results on Feb 14, 2024

Investor sentiment improves as stock rises 16%

Price target increased by 7.3% to ₹1,192

Second quarter 2024 earnings: EPS and revenues exceed analyst expectations

Price target increased by 8.2% to ₹1,070

Narayana Hrudayalaya Limited Approves Dividend for the Financial Year Ended March 31, 2023

Narayana Hrudayalaya Limited Announces Board Retirements, Effective August 7, 2023

Narayana Hrudayalaya Limited to Report Q1, 2024 Results on Aug 02, 2023

Full year 2023 earnings: EPS and revenues exceed analyst expectations

Narayana Hrudayalaya Limited Proposes Dividend for the Financial Year Ended March 31, 2023

Upcoming dividend of ₹2.50 per share at 0.3% yield

Price target increased by 7.5% to ₹943

Full year 2023 earnings released: EPS: ₹29.85 (vs ₹16.85 in FY 2022)

Narayana Hrudayalaya Limited, Annual General Meeting, Aug 04, 2023

Narayana Hrudayalaya Limited to Report Q4, 2023 Results on May 19, 2023

Price target increased by 7.4% to ₹878

Narayana Hrudayalaya Limited Announces Board Appointments

Narayana Hrudayalaya Limited to Report Q3, 2023 Results on Feb 08, 2023

Narayana Hrudayalaya Limited Files Application for Strike-Off of Name of Wholly Owned Subsidiary, Narayana Health Institutions Private Limited

Insufficient new directors

Second quarter 2023 earnings: EPS and revenues exceed analyst expectations

Narayana Hrudayalaya Limited to Report Q2, 2023 Results on Nov 09, 2022

Narayana Hrudayalaya Limited (NSEI:NH) acquired Orthopedic and Trauma Hospital in Bengaluru from Shiva And Shiva Orthopaedic Hospital Private Limited.

Narayana Hrudayalaya Limited (NSEI:NH) signed a Business Transfer Agreement to acquire Orthopedic and Trauma Hospital in Bengaluru from Shiva And Shiva Orthopaedic Hospital Private Limited for INR 2 billion.

Narayana Hrudayalaya Limited (NSEI:NH) signed a Business Transfer Agreement to acquire Orthopedic and Trauma Hospital in Bengaluru from Shiva And Shiva Orthopaedic Hospital Private Limited for INR 2 billion.

Narayana Hrudayalaya Limited Approves the Dividend for the Financial Year Ended 31 March 2022

Upcoming dividend of ₹1.00 per share

Narayana Hrudayalaya Limited Proposes Dividend for the Financial Year Ended 31 March 2022

First quarter 2023 earnings: EPS and revenues exceed analyst expectations

Narayana Hrudayalaya Limited to Report Q1, 2023 Results on Aug 08, 2022

Narayana Health Announces Appointment of Ashish Bajaj as the Chief Marketing Officer

Full year 2022 earnings: EPS misses analyst expectations

Narayana Hrudayalaya Limited Recommends Dividend for the Year Ended March 31, 2022

Insufficient new directors

Insufficient new directors

Narayana Hrudayalaya Limited Announces Appointment of Viren Prasad Shetty as Executive Vice-Chairman

Insufficient new directors

Price target increased to ₹707

Third quarter 2022 earnings: EPS and revenues exceed analyst expectations

Second quarter 2022 earnings released: EPS ₹4.89 (vs ₹0.17 loss in 2Q 2021)

First quarter 2022 earnings released: EPS ₹3.75 (vs ₹5.90 loss in 1Q 2021)

Additional Non-Executive & Independent Director Nivruti Rai has left the company

Full year 2021 earnings released: ₹0.70 loss per share (vs ₹5.86 profit in FY 2020)

Price target increased to ₹525

Narayana Hrudayalaya Limited to Report Q3, 2021 Results on Feb 05, 2021

Narayana Hrudayalaya Limited Announces Resignation of Manohar Dayaram Chatlani from the Position of Independent Director

Narayana Hrudayalaya Limited Announces Discontinuation of Operation and Sale of Heart Centre in Durgapur, West Bengal

New 90-day high: ₹450

Price target raised to ₹393

New 90-day high: ₹386

New 90-day high: ₹367

Narayana Health in India Joins the Trinetx Network to Drive Innovation and Attract Global Clinical Trials

Second quarter 2021 earnings released: ₹0.17 loss per share

Revenue beats expectations, earnings disappoint

New 90-day high: ₹347

Narayana Hrudayalaya Limited to Report Q1, 2021 Results on Aug 04, 2020

First quarter earnings released

New 90-day high - ₹302

CEO Compensation Analysis

CEO

Tenure

Compensation

Leadership Team

Average Tenure

Average Age

Board Members

Average Tenure